Andy Tompkins, MD, MHS

PARC Advisory Board Member
Associate Professor
Psychiatry
+1 628 206-3645
Publications: 

Randomized controlled trial of zolpidem as a pharmacotherapy for cannabis use disorder.

Journal of substance use and addiction treatment

Lee DC, Schlienz NJ, Herrman ES, Martin EL, Leoutsakos J, Budney AJ, Smith MT, Tompkins DA, Hampson AJ, Vandrey R

Substance Use in the Performing Artist with Chronic Pain.

Medical problems of performing artists

Hay KR, Jardot J, Huhn AS, Tompkins DA

A Qualitative Investigation Into Faith and LGBTQ Identities in a Nonclinical Sample of Readers of the Dear Abby Column: The Dear Abby Project.

The Journal of nervous and mental disease

Ghazzawi A, Casoy F, Libby N, McIntosh C, Barber M, Adelson S, Ahola J, Ashley K, Chavez AM, Erickson-Schroth L, Fadus M, Goldenberg D, Hung K, Lothwell L, Mattson M, McAfee SG, Nowaskie DZ, Schwartz A, Tompkins DA, Yarbrough ER, Drescher J

Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.

Drug and alcohol dependence

Agin-Liebes G, Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Gruber VA, Tompkins DA

Experimental sleep disruption attenuates morphine analgesia: findings from a randomized trial and implications for the opioid abuse epidemic.

Scientific reports

Smith MT, Mun CJ, Remeniuk B, Finan PH, Campbell CM, Buenaver LF, Robinson M, Fulton B, Tompkins DA, Tremblay JM, Strain EC, Irwin MR

Religious faith and transgender identities: The Dear Abby project

Journal of Gay & Lesbian Mental Health

Alhasan Ghazzawi, Selena Suhail-Sindhu, Flávio Casoy, Naomi Libby, Christopher A. McIntosh, Stewart Adelson, Kenneth Ashley, Jack Drescher, David Goldenberg, Kenneth Hung, Lorraine E. Lothwell, Marlin R. Mattson, Scot G. McAfee, Alan Schwartz, D. Andrew Tompkins, Eric Yarbrough & Mary E. Barber

The relationship between pupil diameter and other measures of opioid withdrawal during naloxone precipitated withdrawal.

Drug and alcohol dependence

Bergeria CL, Huhn AS, Tompkins DA, Bigelow GE, Strain EC, Dunn KE

Recovery Goals and Long-term Treatment Preference in Persons Who Engage in Nonmedical Opioid Use.

Journal of addiction medicine

Hay KR, Huhn AS, Tompkins DA, Dunn KE

Sex differences in measures of central sensitization and pain sensitivity to experimental sleep disruption: implications for sex differences in chronic pain.

Sleep

Smith MT, Remeniuk B, Finan PH, Speed TJ, Tompkins DA, Robinson M, Gonzalez K, Bjurstrom MF, Irwin MR

Analgesic Effects of Hydromorphone versus Buprenorphine in Buprenorphine-maintained Individuals.

Anesthesiology

Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Tompkins DA

Extended-release injectable naltrexone (XR-NTX): a response to clinical issues raised by Brewer & Streel.

Addiction (Abingdon, England)

Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow G, Silverman K

Prefrontal cortex response to drug cues, craving, and current depressive symptoms are associated with treatment outcomes in methadone-maintained patients.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

Huhn AS, Sweeney MM, Brooner RK, Kidorf MS, Tompkins DA, Ayaz H, Dunn KE

Preliminary evidence of different and clinically meaningful opioid withdrawal phenotypes.

Addiction biology

Dunn KE, Weerts EM, Huhn AS, Schroeder JR, Tompkins DA, Bigelow GE, Strain EC

Psychiatric Disorders and Comorbid Cannabis Use: When Should We Be Concerned and What Can We Do About It?

The Journal of clinical psychiatry

Satre DD, Borsari B, Tompkins DA, Ramo D

Outpatient transition to extended-release injectable naltrexone for patients with opioid use disorder: A phase 3 randomized trial.

Drug and alcohol dependence

Bisaga A, Mannelli P, Yu M, Nangia N, Graham CE, Tompkins DA, Kosten TR, Akerman SC, Silverman BL, Sullivan MA

Extended-release injectable naltrexone for opioid use disorder: a systematic review.

Addiction (Abingdon, England)

Jarvis BP, Holtyn AF, Subramaniam S, Tompkins DA, Oga EA, Bigelow GE, Silverman K

Ethnic Differences in the Effects of Naloxone on Sustained Evoked Pain: A Preliminary Study.

Diversity and equality in health and care

Burton EF, Suen SY, Walker JL, Bruehl S, Peterlin BL, Tompkins DA, Buenaver LF, Edwards RR, Campbell CM

Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.

JAMA psychiatry

Dunn KE, Tompkins DA, Bigelow GE, Strain EC

Pain catastrophizing may moderate the association between pain and secondary hyperalgesia.

Journal of applied biobehavioral research

Pressman AJ, Peterlin BL, Tompkins DA, Salas RE, Buenaver LF, Haythornthwaite JA, Campbell CM

The Growing Regulation of Conversion Therapy.

Journal of medical regulation

Drescher J, Schwartz A, Casoy F, McIntosh CA, Hurley B, Ashley K, Barber M, Goldenberg D, Herbert SE, Lothwell LE, Mattson MR, McAfee SG, Pula J, Rosario V, Tompkins DA

Recruitment techniques for alcohol pharmacotherapy clinical trials: A cost-benefit analysis.

Addictive disorders & their treatment

Tompkins DA, Sides JA, Harrison JA, Strain EC

Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients.

Drug and alcohol dependence

Dunn KE, Finan PH, Tompkins DA, Fingerhood M, Strain EC

Topiramate for cocaine dependence during methadone maintenance treatment: a randomized controlled trial.

Drug and alcohol dependence

Umbricht A, DeFulio A, Winstanley EL, Tompkins DA, Peirce J, Mintzer MZ, Strain EC, Bigelow GE

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Drug and alcohol dependence

Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K

The effect of repeated intramuscular alfentanil injections on experimental pain and abuse liability indices in healthy males.

The Clinical journal of pain

Tompkins DA, Smith MT, Bigelow GE, Moaddel R, Venkata SL, Strain EC

A double blind, within subject comparison of spontaneous opioid withdrawal from buprenorphine versus morphine.

The Journal of pharmacology and experimental therapeutics

Tompkins DA, Smith MT, Mintzer MZ, Campbell CM, Strain EC

Opioid abusers' ability to differentiate an opioid from placebo in laboratory challenge testing.

Drug and alcohol dependence

Antoine DG, Strain EC, Tompkins DA, Bigelow GE

Report of the American Psychiatric Association Task Force on Treatment of Gender Identity Disorder.

Archives of sexual behavior

Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle EJ, Meyer-Bahlburg HF, Pleak RR, Tompkins DA

Treatment of gender identity disorder.

The American journal of psychiatry

Byne W, Bradley SJ, Coleman E, Eyler AE, Green R, Menvielle E, Meyer-Bahlburg HF, Pleak RR, Tompkins DA

Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?

Current pain and headache reports

Tompkins DA, Campbell CM

Human abuse liability assessment of oxycodone combined with ultra-low-dose naltrexone.

Psychopharmacology

Tompkins DA, Lanier RK, Harrison JA, Strain EC, Bigelow GE

Hematological adverse events in clozapine-treated children and adolescents.

Journal of the American Academy of Child and Adolescent Psychiatry

Gerbino-Rosen G, Roofeh D, Tompkins DA, Feryo D, Nusser L, Kranzler H, Napolitano B, Frederickson A, Henderson I, Rhinewine J, Kumra S